Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/ or retinoic acid receptor-b: but p53 mutations are not necessarily required
Our previous work showed that acquisition of immortality at the dysplasia stage of oral cancer progression was consistently associated with four changes: loss of retinoic acid receptor (RAR)-b and p16
INK4A expression, p53 mutations and activation of telomerase. One atypical dysplasia (D17) that underwent delayed senescence after an extended lifespan showed loss of INK4A / p14 ARF expression, but retained functional wild-type p53 and telomerase was not activated. We now demonstrate that retroviral delivery of hTERT results in telomere lengthening and immortalization of D17 without loss of functional wild-type p53 activity. In contrast, the expression of hTERT in two other typical mortal dyplasia cultures (that retain INK4A expression) does not extend their lifespan, even though telomeres are lengthened. Oncogene (2003 Oncogene ( ) 22, 7804-7808. doi:10.1038 Keywords: head and neck cancer; preneoplasia; immortalization; RAR-b; INK4A; telomerase Normal cells undergo replicative senescence in culture due to the erosion of telomeres and fail to divide further but remain viable. Although the role of senescence in vivo remains to be established, escape from senescence and acquisition of immortality are considered to be important characteristics of cancer cells (Campisi, 2000) since most primary cancers, and virtually all recurrences, are immortal (Shay, 1997) . Studies with various cell types have indicated that senescence can be bypassed by abrogation of the p53 and retinoblastoma gene (Rb) pathways, but the cells then enter a second proliferative block (crisis) involving genomic instability and cell death, from which rare immortal variants emerge due to the activation of telomerase and telomere maintenance (Lustig, 1999) . Several studies have reported that some normal cell types can be immortalized by ectopic expression of the catalytic component of telomerase (hTERT) alone, whereas others, such as mammary epithelial cells and keratinocytes, cannot without concomitant loss of p16
INK4A expression (Stewart and Weinberg, 2002) . However, it remains controversial whether this loss of p16
INK4A is due to suboptimal culture conditions or simply passage in culture (Stewart and Weinberg, 2002) . Senescence can also be induced by oncogene expression in cultured cells (Serrano et al., 1997) . However, it is not clear whether the mechanisms of escape from senescence by normal cells are the same as those in mortal preneoplastic cells since, for example, p16
INK4A is known to be regulated positively and negatively by oncogenes (Ohtani et al., 2001) . This report addresses these issues in a head and neck/oral keratinocyte preneoplasia model of squamous cell carcinoma (SCC) development. In our previous work, we showed that acquisition of immortality at the dysplasia stage of oral SCC was consistently associated with loss of retinoic acid receptor (RAR)-b and p16 INK4A expression, p53 mutations and activation of telomerase, suggesting that all are required for immortality (McGregor et al., 1997 (McGregor et al., , 2002 . Typically, none of the mortal dysplasias (for example, D30 and D25 used in the present study) showed any of these changes. However, one atypical mortal dysplasia (D17) had an extended lifespan and an intermediate molecular phenotype, that is, loss of retinoic acid receptor (RAR)-b and p16
INK4A
expression, but not p53 mutations and activation of telomerase. The loss of INK4A expression in D17 is not a culture artefact, since we have also shown loss of both markers in the biopsy from which D17 was derived (data not shown).
In this report, we have tested whether the ectopic activation of telomerase by transduction of a retroviral hTERT expression vector is sufficient to immortalize naturally occurring oral dysplasias, or whether other changes, such as p53 mutations and loss of INK4A expression are also required. We therefore used the amphotropic retroviral vector pBabeEST to express hTERT ectopically into two typical mortal cultures (D25, D30) and also D17. Parallel cultures were also infected with the 'empty' retroviral vector expressing the neomycin resistance gene alone. After infection, neomycin-resistant colonies were pooled, checked for telomerase activity and telomere lengths as soon as sufficient cells were available and monitored for their lifespan. The mortal dysplasia culture D30 had an expected lifespan of 30 PDs and was infected at 8.5, 9, 17 and 18 PDs in four separate experiments. D25 had an expected lifespan of 25 PDs and was infected at 7, 9 and 18 PDs in three separate experiments. In parallel experiments, the D17 dysplasia culture was infected after having reached 34.5 and 39 PDs, with an expected lifespan of 45 PDs. With D25 and D30 dyplasias, no extension in lifespan was observed after infection with the hTERT vector, compared to infection with the vector control or uninfected cells: for example, D30 cells infected with either the empty vector or the hTERT vector at 9 PD both entered terminal growth arrest after 28 PD, compared to 30 PD for uninfected D30 cells. However, with D17, the cells infected with the hTERT vector appear to be immortal (to date, they have reached 130 PDs when they are still proliferating rapidly), but this did not occur with uninfected cells or cells infected with the 'empty' vector, which underwent delayed senescence at about 45 PD like the uninfected cells ( Figure 1 ). All the mortal dysplasia cultures underwent terminal growth arrest due to senescence rather than 'crisis', since the arrested colonies show no apoptosis by TUNEL staining and the percentage of proliferating cells by BrdU labelling is low (less than 20%) ( Figure 1 ).
To check whether the dysplasias infected with the hTERT vector had functional telomerase, telomerase activity as well as telomere length maintenance was assayed. In both D30 and D17, telomerase activity was undetectable in uninfected cultures and cultures infected with the empty vector, but activity was readily detectable in cultures infected with the hTERT vector ( Figure 2 ). In both cases, the activation of telomerase after infection with the hTERT vector was functional in maintaining/ elongating telomeres: during culture of D30 and D17 to senescence, telomere restriction fragment lengths (TRFs) progressively became shorter, but were increased significantly after infection with the hTERT vector, but not the 'empty' vector ( Figure 3) . Overall, these experiments expressing hTERT ectopically in D30/D25 and D17 strongly suggest that telomerase activation/telomere maintenance is not sufficient per se to immortalize naturally occurring mortal dysplasias unless they have lost the expression of RAR-b and/or p16
. Loss of p16
INK4A and RAR-b in dysplasias is not an in vitro artefact, since both changes have been found in a large fraction of dysplasias in vivo (Xu et al., 1994; Papadimitrakopoulou et al., 1997) . In a similar way, recent work sequentially abrogating Rb and p53 responses in human fibroblasts demonstrated extensions in lifespan, but not immortalization (Morris et al., 2002) .
However, a recent report showed that in normal human keratinocytes, p16 dysfunction and telomerase overexpression were insufficient for immortalization and that p53 dysfunction was also required (Rheinwald et al., 2002) . The authors observed an upregulation of p14 ARF in normal keratinocytes depleted of p16 function after they had proliferated beyond their normal lifespan limit. Since p14 ARF can stabilize p53 by inhibiting the MDM2 ubiquitin ligase (see Rheinwald et al. (2002) and references therein), the accumulation of p14 ARF may elevate the p53 level and this may be the reason for the necessity to disrupt additionally the p53 pathway subsequently in order to obtain immortalization in their experiments. On the basis of these results, Rheinwald et al. (2002) suggested that the telomere-mediated activation of p53 by short telomeres, previously shown to occur in human fibroblasts (Webley et al., 2000) , Colonies were also stained with propidium iodide (red stain) to identify nuclear DNA. Colonies were analysed during terminal growth arrest or at 85 PDs in the case of hTERT infected cultures. The methods for isolation, establishment and culture of the primary human oral cultures used in this study have been described previously (McGregor et al., 1997 (McGregor et al., , 2002 . The cultures were derived and maintained using the 3T3 feeder layer culture system of Rheinwald and co-workers, which has been shown to facilitate the growth of keratinocytes at all stages of cancer progression and to maintain the characteristics of the original tumours (Rheinwald and Beckett, 1981) : it has also been reported to avoid the premature growth arrest associated with culture of epithelial cells in chemically defined keratinocyte growth medium directly on plastic culture dishes (Ramirez et al., 2001) . The irradiated 3T3 feeder cells were removed by EDTA treatment before analysis of keratinocytes. Cells were stained for SABG (McGregor et al., 2002) , DNA fragmentation measured by the TUNEL assay (Ghose et al., 2001 ) and the proliferative index of colonies determined by BrdU labelling (Munro et al., 2001) Immortalization of oral dysplasias by hTERT A Muntoni et al might be unnecessary for the senescence of normal human keratinocytes. To address the role of p14 ARF in the immortalization of D17, we attempted to detect p14 ARF by Western blotting and showed that it was undetectable in D17, although p14 ARF could be detected at a very low level in two normal mucosa cultures (FNB3 and FNB5), in one of the mortal dysplasias (D6), in an immortal dysplasia that had mutated p53 (D20) and at a much higher level in one of our SCCs (BICR3) that also had mutated p53 (Figure 4a ). Codeletion of p16 INK4A and p14 ARF proteins has been reported in oral dysplasia by others (Munro et al., 1999; Kresty et al., 2002) . Thus in the neoplastic D17 culture, the codysfunction of p16 and p14 ARF (together with RAR-b) allows these cells to undergo further telomeric attrition and proceed to a delayed senescence checkpoint. The current observations, and those recently reported (Rheinwald et al., 2002) , suggest that p53 can mediate two distinct mechanisms of senescence in neoplastic oral keratinocytes.
Since our previous work demonstrated a frequent association between p53 mutations, telomerase activation and acquisition of immortality in our series of oral dysplasia cultures (McGregor et al., 1997 (McGregor et al., , 2002 , we determined whether immortalization of our D17 culture by hTERT/telomerase activation also required p53 mutation. However, sequencing of the entire p53 coding region using DNA from the hTERT infected D17 culture at >100 PDs showed it to be wild type, like the uninfected D17 parent (McGregor et al., 2002) . The upstream pathway regulating wild-type p53 appears to be functional in both D17 cells and D17 cells immortalized by hTERT infection since the p53 protein level is inducible by UV in both cases (Figure 4b) . Moreover, the levels of p21 (WAF1) protein, a wellrecognized target of wild-type p53, are increased by UV treatment both in D17 cells and D17 cells immortalized by hTERT infection (Figure 4b ). This indicates that the p53 present in D17 cells and hTERT-immortalized D17 cells is transcriptionally active. Finally, we measured the level of phosphorylation of p53 at serine 15 during the passage of D17 cells and after immortalization of D17 cells by hTERT infection, since this site is known to be involved in response to telomere shortening at senescence as well as in wild-type p53-mediated DNA damage responses (Webley et al., 2000) and seems to be a sensor Figure 3 Telomere length in D30 and D17 dysplasias after infection with hTERT retrovirus. TRF lengths were measured by Southern blotting in D30 and D17 cultures at different stages of their lifespan, comprising senescence (the number of population doubling is indicated for each sample), after infection with the empty vector and with the hTERT transducing vector (hTERT). With both D 30 and D 17, the intensity of signals with the 'empty' vector infected cultures is weaker than for the other samples due to the small amounts of DNA available, but show that the TRFs are significantly shorter than in cells infected with the hTERT vector. The high molecular weight smears in the D17 experiment (particularly lanes 3 and 7) are often seen in keratinocyte TRF blots (Gordon et al., 2002) and are probably due to small amounts of 3T3 DNA contamination that gave a disproportionately high signal because mouse TRFs are 10-25 more abundant than in our human oral cultures. TRF measurements were carried out as described by Munro et al. (2001) , except that the blot was hybridized with a radiolabelled oligonucleotide probe (TTAGGG) 3 at 421C and subsequently washed in 6 Â SSC/1% SDS at 421C Figure 2 Telomerase activity in D30 and D17 cultures before and after infection with the hTERT expression vector. D30 cells were infected with hTERT or empty vector retroviruses at 9 PDs and analysed as soon as sufficient cells were available; D17 cells were infected at 39 PDs and analysed at 58 PDs. TRAPeze assay was performed on 400 ng (left panel) or 200 ng (right panel) of the protein extract. The gels show the PCR products generated after staining with ethidium bromide. WI38 and HeLa cells were included as telomerase-negative and -positive controls, respectively. The retroviruses were produced by infecting the amphotropic packaging line Phoenix A with pBabeNeo or pBabest2 (hTERT) retroviral constructs (Vaziri and Benchimol, 1998) and selecting the minimum concentration of G418 found to kill the uninfected cultures. Dysplasia cultures were infected at about 80% confluency with 1.35 Â 10 4 infectious units/ml in the presence of 4 mg/ml of polybrene. The dysplasia cells were plated on G418-resistant 3T3 feeder cells, selected 48 h later with 200 mg/ml of G418 and cultured under constant selection. Pooled G418-resistant colonies were used in all experiments to avoid variability due to clonal heterogeneity of the population. Epithelial cells were removed from the irradiated feeders before analysis by extensive washing with PBS/EDTA as described previously (McGregor et al., 2002) : this has been shown to result in less than 5% contamination of epithelial cells with 3T3 feeders. Telomerase activity was also measured as described previously (McGregor et al., 2002) of DNA damage signals relayed by the ATM pathway in response to critically short telomeres (Webley et al., 2000; Pandita, 2002) . The degree of serine 15 p53 phosphorylation increases during D17 delayed senescence, but is decreased in D17 cells immortalized by hTERT transduction (Figure 4c ). These combined data strongly suggest that the wild-type p53 pathway in hTERT-immortalized D17 cells is functional, but no longer requires to be activated after telomerase activation. Thus, p53 mutation is not an obligatory requirement for immortalization of oral dysplasias provided that telomerase is activated exogenously. Wild-type p53 is known to downregulate hTERT in other contexts (Xu et al., 2000) and thus p53 mutation may be one route for hTERT/telomerase activation for the acquisition of immortality during oral dysplasia progression. Alternatively, since p53 appears to sense telomere dysfunction to mediate a G1 cell cycle checkpoint (Webley et al., 2000; Pandita, 2002) , correcting telomere dysfunction by ectopically activating telomerase may remove any requirement for p53 mutation in this situation. Clearly, these alternatives are not mutually exclusive and abrogation of other functions of wild-type p53 may be required for the development of other aspects of the cancer cell phenotype.
A final point of interest from our D17 data concerns the debate regarding the importance of p16 pathway in sensing telomere dysfunction in human cells (Ramirez et al., 2001; Smogorzewska and de Lange, 2002) . The D17 culture has average telomere lengths of around 5 kb after 12 PDs in vitro (Figure 3) , implying even longer telomeres in vivo: this is considerably greater than the telomere length of 3 kb at which phosphorylation of p53 at serine 15 occurs (Figure 4c ). Since we have shown p16 to be clearly absent in D17 cells in vivo as well as in vitro (data not shown), selection against p16 is unlikely to have occurred in D17 in vivo in response to short telomeres. ARF levels at various stages of progression towards senescence. D17 cells were analysed at various stages towards delayed senescence and at 96 PDs after immortalization by infection with hTERT retrovirus. An SCC previously shown to express p14 ARF (BICR 3) (Munro et al., 1999) was included as a positive control. An immortal dysplasia (D20), a typical mortal dysplasia (D6) and two normal mucosa cultures (FNB3 and FNB5) were also included. D20 had mutated p53. (b) Effect of UV on the levels of p53 and p21 WAF proteins in D17 cells at 23 PDs and D17 cells immortalized by hTERT infection after 96 PDs. Cells were exposed to UV (about 10 4 mJ/cm 2 ) for the stated periods of time and the levels of total p53 and p21 WAF were measured by Western blotting. (c) Total p53 levels and p53 phosphorylation status at serine 15. D17 cultures at various stages of progression towards senescence, or after infection with the hTERT vector were analysed for the levels of p53 and phosphoserine15 p53 status by Western blotting. In (a), (b) and (c), reprobing of the blots to measure the levels of ERK 1-2 were included as loading controls. The BICR 3 sample in (a) was deliberately underloaded since the level of p14 ARF is known to be extremely high. The levels of total p53, p53 phosphorylated at serine 15, p14 ARF, p21 and ERK 1-2 were determined by Western blotting using the following antibodies as indicated by the manufacturers: total p53 (D01; Santa Cruz Biotechnology); ser 15 phospho-specific p53 (16G8, New England BioLabs); p14ARF (C-18, sc-8613; Santa Cruz Biotechnology); p21 (Cip1/WAF1 antibody 610233, BD Transduction Laboratories, Oxford); ERK 1-2 (ERK1(C-16)-G; Santa Cruz Biotechnology). DNA was isolated from hTERT-transduced D17 cultures once they had reached 86 population doublings. Sequencing of exons 2-11 was performed as described previously (McGregor et al., 2002) 
